Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-11-12

Clinical Trial Update: A Study of ASP1941 in Combination With Insulin in Patients With Type 1 Diabetes Mellitus [Phase 3]

View source ↗

Summary

Phase 3 study evaluating ASP1941 in combination with insulin for Type 1 diabetes mellitus has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ASP-1941 (ASP-1941)
  • Insulin (insulin)

Snippet

Sponsor: Astellas Pharma Inc | Conditions: Type 1 Diabetes Mellitus | Phase 3 | Status: COMPLETED